123 related articles for article (PubMed ID: 34397726)
1. Aberrant PTEN, PIK3CA, pMAPK, and TP53 expression in human scalp and face angiosarcoma.
Wan H; Zhang D; Hu W; Xie Z; Du Q; Xia Q; Wen T; Jia H
Medicine (Baltimore); 2021 Jul; 100(30):e26779. PubMed ID: 34397726
[TBL] [Abstract][Full Text] [Related]
2. Active TGF-β signaling and decreased expression of PTEN separates angiosarcoma of bone from its soft tissue counterpart.
Verbeke SL; Bertoni F; Bacchini P; Oosting J; Sciot R; Krenács T; Bovée JV
Mod Pathol; 2013 Sep; 26(9):1211-21. PubMed ID: 23599148
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics.
Italiano A; Chen CL; Thomas R; Breen M; Bonnet F; Sevenet N; Longy M; Maki RG; Coindre JM; Antonescu CR
Cancer; 2012 Dec; 118(23):5878-87. PubMed ID: 22648906
[TBL] [Abstract][Full Text] [Related]
4. PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer.
Herzog A; Bian Y; Vander Broek R; Hall B; Coupar J; Cheng H; Sowers AL; Cook JD; Mitchell JB; Chen Z; Kulkarni AB; Van Waes C
Clin Cancer Res; 2013 Jul; 19(14):3808-19. PubMed ID: 23640975
[TBL] [Abstract][Full Text] [Related]
5. Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face.
Tokuyama W; Mikami T; Masuzawa M; Okayasu I
Hum Pathol; 2010 Mar; 41(3):407-14. PubMed ID: 19913279
[TBL] [Abstract][Full Text] [Related]
6. p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas.
Singh B; Reddy PG; Goberdhan A; Walsh C; Dao S; Ngai I; Chou TC; O-Charoenrat P; Levine AJ; Rao PH; Stoffel A
Genes Dev; 2002 Apr; 16(8):984-93. PubMed ID: 11959846
[TBL] [Abstract][Full Text] [Related]
7. Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer.
Loibl S; Darb-Esfahani S; Huober J; Klimowicz A; Furlanetto J; Lederer B; Hartmann A; Eidtmann H; Pfitzner B; Fasching PA; Tiemann K; Jackisch C; Mehta K; von Minckwitz G; Untch M; Denkert C
Clin Cancer Res; 2016 Jun; 22(11):2675-83. PubMed ID: 26758558
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients.
Li G; Guo X; Chen M; Tang L; Jiang H; Day JX; Xie Y; Peng L; Xu X; Li J; Wang S; Xiao Z; Dai L; Wang J
PLoS One; 2018; 13(9):e0203495. PubMed ID: 30212483
[TBL] [Abstract][Full Text] [Related]
9. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research.
Painter CA; Jain E; Tomson BN; Dunphy M; Stoddard RE; Thomas BS; Damon AL; Shah S; Kim D; Gómez Tejeda Zañudo J; Hornick JL; Chen YL; Merriam P; Raut CP; Demetri GD; Van Tine BA; Lander ES; Golub TR; Wagle N
Nat Med; 2020 Feb; 26(2):181-187. PubMed ID: 32042194
[TBL] [Abstract][Full Text] [Related]
10. PIK3CA and PTEN Genes Expressions in Breast Cancer.
Alowiri NH; Hanafy SM; Haleem RA; Abdellatif A
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2841-2846. PubMed ID: 31554385
[TBL] [Abstract][Full Text] [Related]
11. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.
Megquier K; Turner-Maier J; Swofford R; Kim JH; Sarver AL; Wang C; Sakthikumar S; Johnson J; Koltookian M; Lewellen M; Scott MC; Schulte AJ; Borst L; Tonomura N; Alfoldi J; Painter C; Thomas R; Karlsson EK; Breen M; Modiano JF; Elvers I; Lindblad-Toh K
Mol Cancer Res; 2019 Dec; 17(12):2410-2421. PubMed ID: 31570656
[TBL] [Abstract][Full Text] [Related]
12. Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia.
Yip WK; Choo CW; Leong VC; Leong PP; Jabar MF; Seow HF
APMIS; 2013 Oct; 121(10):954-66. PubMed ID: 23992303
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities.
Millis SZ; Jardim DL; Albacker L; Ross JS; Miller VA; Ali SM; Kurzrock R
Cancer; 2019 Apr; 125(7):1185-1199. PubMed ID: 30582752
[TBL] [Abstract][Full Text] [Related]
14. Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck.
Pickhard A; Gröber S; Haug AK; Piontek G; Wirth M; Straßen U; Rudelius M; Reiter R
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):733-42. PubMed ID: 24726415
[TBL] [Abstract][Full Text] [Related]
15. Mutation of the PTEN gene in a human hepatic angiosarcoma.
Tate G; Suzuki T; Mitsuya T
Cancer Genet Cytogenet; 2007 Oct; 178(2):160-2. PubMed ID: 17954274
[TBL] [Abstract][Full Text] [Related]
16. EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab.
Gori S; Sidoni A; Colozza M; Ferri I; Mameli MG; Fenocchio D; Stocchi L; Foglietta J; Ludovini V; Minenza E; De Angelis V; Crinò L
Ann Oncol; 2009 Apr; 20(4):648-54. PubMed ID: 19188134
[TBL] [Abstract][Full Text] [Related]
17. Selective gene expression profiling of mTOR-associated tumor suppressor and oncogenes in ovarian cancer.
Laudański P; Kowalczuk O; Klasa-Mazurkiewicz D; Milczek T; Rysak-Luberowicz D; Garbowicz M; Baranowski W; Charkiewicz R; Szamatowicz J; Chyczewski L
Folia Histochem Cytobiol; 2011; 49(2):317-24. PubMed ID: 21744334
[TBL] [Abstract][Full Text] [Related]
18. Aberrant Akt Activation During Implantation Window in Infertile Women With Intramural Uterine Fibroids.
Makker A; Goel MM; Nigam D; Mahdi AA; Das V; Agarwal A; Pandey A; Gautam A
Reprod Sci; 2018 Aug; 25(8):1243-1253. PubMed ID: 29113583
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of PIK3CA impacts global survival of patients with HER2 subtype breast carcinoma.
Iensen Felicidade S; Ferreira Salles Pilar E; Predebom Flores Texeira J; Watte G; Remonatto G; Sant Anna Alves RC; Vial Roehe A
J BUON; 2020; 25(6):2546-2551. PubMed ID: 33455095
[TBL] [Abstract][Full Text] [Related]
20. Molecular Profile of Canine Hemangiosarcoma and Potential Novel Therapeutic Targets.
Pimentel PAB; Giuliano A; Bęczkowski PM; Horta RDS
Vet Sci; 2023 Jun; 10(6):. PubMed ID: 37368773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
